The role of adiposity, diet and inflammation on the discordance between LDL-C and apolipoprotein B.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
03 2022
Historique:
received: 04 06 2021
revised: 21 10 2021
accepted: 03 12 2021
pubmed: 7 2 2022
medline: 11 3 2022
entrez: 6 2 2022
Statut: ppublish

Résumé

While low-density lipoprotein cholesterol (LDL-C) is a good predictor of atherosclerotic cardiovascular disease, apolipoprotein B (ApoB) is superior when the two markers are discordant. We aimed to determine the impact of adiposity, diet and inflammation upon ApoB and LDL-C discordance. Machine learning (ML) and structural equation models (SEMs) were applied to the National Health and Nutrition Examination Survey to investigate cardiometabolic and dietary factors when LDL-C and ApoB are concordant/discordant. Mendelian randomisation (MR) determined whether adiposity and inflammation exposures were causal of elevated/decreased LDL-C and/or ApoB. ML showed body mass index (BMI), dietary saturated fatty acids (SFA), dietary fibre, serum C-reactive protein (CRP) and uric acid were the most strongly associated variables (R Our data show increased discordance between ApoB and LDL-C is associated with cardiometabolic, clinical and dietary abnormalities and that body fat percentage is causal of elevated ApoB.

Sections du résumé

BACKGROUND AND AIMS
While low-density lipoprotein cholesterol (LDL-C) is a good predictor of atherosclerotic cardiovascular disease, apolipoprotein B (ApoB) is superior when the two markers are discordant. We aimed to determine the impact of adiposity, diet and inflammation upon ApoB and LDL-C discordance.
METHODS AND RESULTS
Machine learning (ML) and structural equation models (SEMs) were applied to the National Health and Nutrition Examination Survey to investigate cardiometabolic and dietary factors when LDL-C and ApoB are concordant/discordant. Mendelian randomisation (MR) determined whether adiposity and inflammation exposures were causal of elevated/decreased LDL-C and/or ApoB. ML showed body mass index (BMI), dietary saturated fatty acids (SFA), dietary fibre, serum C-reactive protein (CRP) and uric acid were the most strongly associated variables (R
CONCLUSION
Our data show increased discordance between ApoB and LDL-C is associated with cardiometabolic, clinical and dietary abnormalities and that body fat percentage is causal of elevated ApoB.

Identifiants

pubmed: 35123856
pii: S0939-4753(21)00563-9
doi: 10.1016/j.numecd.2021.12.004
pii:
doi:

Substances chimiques

Apolipoprotein B-100 0
Apolipoproteins B 0
Cholesterol, LDL 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-615

Informations de copyright

Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None declared.

Auteurs

Richard J Webb (RJ)

School of Health Sciences, Faculty of Science, Liverpool Hope University, Hope Park Campus, Taggart Avenue, Liverpool, L16 9JD, United Kingdom. Electronic address: webbr1@hope.ac.uk.

Mohsen Mazidi (M)

Nuffield Department of Population Health, Richard Doll Building, Old Road Campus, University of Oxford, Oxford, OX3 7LF, United Kingdom; Department of Twin Research & Genetic Epidemiology, King's College London, 4th Floor, South Wing, St Thomas', London, SE1 7EH, United Kingdom. Electronic address: mohsen.mazidi@ndph.ox.ac.uk.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool L14 3PE, United Kingdom; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, DK-9100 Aalborg, Denmark. Electronic address: gregory.lip@liverpool.ac.uk.

Andre P Kengne (AP)

Non-Communicable Diseases Research Unit, South African Medical Research Council, 7505, Cape Town, South Africa. Electronic address: Andre.Kengne@mrc.ac.za.

Maciej Banach (M)

Cardiovascular Research Centre, University of Zielona Gora, 65-046, Zielona Gora, Poland; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), 93-338, Lodz, Poland. Electronic address: maciej.banach@umed.lodz.pl.

Ian G Davies (IG)

Research Institute of Sport and Exercise Science, Liverpool John Moores University, Liverpool, L3 3AF, United Kingdom. Electronic address: I.G.Davies@ljmu.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH